IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.
about
Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4.MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.Serum and exosomal miR-122 and miR-199a as a biomarker to predict therapeutic efficacy of hepatitis C patients.
P2860
IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
IFI35, mir-99a and HCV genotyp ...... avirin in chronic hepatitis C.
@ast
IFI35, mir-99a and HCV genotyp ...... avirin in chronic hepatitis C.
@en
type
label
IFI35, mir-99a and HCV genotyp ...... avirin in chronic hepatitis C.
@ast
IFI35, mir-99a and HCV genotyp ...... avirin in chronic hepatitis C.
@en
prefLabel
IFI35, mir-99a and HCV genotyp ...... avirin in chronic hepatitis C.
@ast
IFI35, mir-99a and HCV genotyp ...... avirin in chronic hepatitis C.
@en
P2093
P2860
P1433
P1476
IFI35, mir-99a and HCV genotyp ...... avirin in chronic hepatitis C.
@en
P2093
Emilie Estrabaud
Kevin Appourchaux
Martine Lapalus
Michel Vidaud
Michelle Martinot-Peignoux
Nathalie Boyer
Olivier Lada
Patrick Marcellin
Tarik Asselah
P2860
P304
P356
10.1371/JOURNAL.PONE.0121395
P407
P577
2015-04-06T00:00:00Z